Interferon Regulatory Factor 8 Modulates Phenotypic Switching of Smooth Muscle Cells by Regulating the Activity of Myocardin

REFERENCES

• Dzau VJ, Braun-Dullaeus RC, Sedding DG. 2002. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8:1249–1256. http://dx.doi.org/10.1038/nm1102-1249.
   PubMed Web of Science ®Google Scholar
• Owens GK, Kumar MS, Wamhoff BR. 2004. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84:767–801. http://dx.doi.org/10.1152/physrev.00041.2003.
   PubMed Web of Science ®Google Scholar
• Gibbons GH, Dzau VJ. 1994. The emerging concept of vascular remodeling. N. Engl. J. Med. 330:1431–1438. http://dx.doi.org/10.1056/NEJM199405193302008.
   PubMed Web of Science ®Google Scholar
• Kawai-Kowase K, Owens GK. 2007. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 292:C59–C69. http://dx.doi.org/10.1152/ajpcell.00394.2006.
   PubMed Web of Science ®Google Scholar
• Wamhoff BR, Hoofnagle MH, Burns A, Sinha S, McDonald OG, Owens GK. 2004. A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ. Res. 95:981–988. http://dx.doi.org/10.1161/01.RES.0000147961.09840.fb.
   PubMed Web of Science ®Google Scholar
• Regan CP, Adam PJ, Madsen CS, Owens GK. 2000. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J. Clin. Invest. 106:1139–1147. http://dx.doi.org/10.1172/JCI10522.
   PubMed Web of Science ®Google Scholar
• Miano JM. 2003. Serum response factor: toggling between disparate programs of gene expression. J. Mol. Cell. Cardiol. 35:577–593. http://dx.doi.org/10.1016/S0022-2828(03)00110-X.
   PubMed Web of Science ®Google Scholar
• Camoretti-Mercado B, Dulin NO, Solway J. 2003. Serum response factor function and dysfunction in smooth muscle. Respir. Physiol. Neurobiol. 137:223–235. http://dx.doi.org/10.1016/S1569-9048(03)00149-6.
   PubMedGoogle Scholar
• Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. 2004. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature 428:185–189. http://dx.doi.org/10.1038/nature02382.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH, Owens GK. 2005. Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J. Biol. Chem. 280:9719–9727. http://dx.doi.org/10.1074/jbc.M412862200.
   PubMedGoogle Scholar
• Yoshida T, Gan Q, Owens GK. 2008. Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am. J. Physiol. Cell Physiol. 295:C1175–C1182. http://dx.doi.org/10.1152/ajpcell.00288.2008.
   PubMedGoogle Scholar
• Doi H, Iso T, Yamazaki M, Akiyama H, Kanai H, Sato H, Kawai-Kowase K, Tanaka T, Maeno T, Okamoto E, Arai M, Kedes L, Kurabayashi M. 2005. HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box. Arterioscler. Thromb. Vasc. Biol. 25:2328–2334. http://dx.doi.org/10.1161/01.ATV.0000185829.47163.32.
   PubMedGoogle Scholar
• Tamura T, Yanai H, Savitsky D, Taniguchi T. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26:535–584. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090400.
   PubMed Web of Science ®Google Scholar
• Savitsky D, Tamura T, Yanai H, Taniguchi T. 2010. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 59:489–510. http://dx.doi.org/10.1007/s00262-009-0804-6.
   PubMed Web of Science ®Google Scholar
• Honda K, Taniguchi T. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644–658. http://dx.doi.org/10.1038/nri1900.
   PubMed Web of Science ®Google Scholar
• Lu J, Bian ZY, Zhang R, Zhang Y, Liu C, Yan L, Zhang SM, Jiang DS, Wei X, Zhu XH, Chen M, Wang AB, Chen Y, Yang Q, Liu PP, Li H. 2013. Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy. Basic Res. Cardiol. 108:326. http://dx.doi.org/10.1007/s00395-012-0326-9.
   PubMed Web of Science ®Google Scholar
• Jiang DS, Bian ZY, Zhang Y, Zhang SM, Liu Y, Zhang R, Chen Y, Yang Q, Zhang XD, Fan GC, Li H. 2013. Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy. Hypertension 61:1193–1202. http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.00614.
   PubMedGoogle Scholar
• Wang XA, Zhang R, Jiang D, Deng W, Zhang S, Deng S, Zhong J, Wang T, Zhu LH, Yang L, Hong S, Guo S, Chen K, Zhang XF, She Z, Chen Y, Yang Q, Zhang XD, Li H. 2013. Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice. Hepatology 58:603–616. http://dx.doi.org/10.1002/hep.26368.
   PubMedGoogle Scholar
• Driggers PH, Ennist DL, Gleason SL, Mak WH, Marks MS, Levi BZ, Flanagan JR, Appella E, Ozato K. 1990. An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. U. S. A. 87:3743–3747. http://dx.doi.org/10.1073/pnas.87.10.3743.
   PubMed Web of Science ®Google Scholar
• Döring Y, Soehnlein O, Drechsler M, Shagdarsuren E, Chaudhari SM, Meiler S, Hartwig H, Hristov M, Koenen RR, Hieronymus T, Zenke M, Weber C, Zernecke A. 2012. Hematopoietic interferon regulatory factor 8-deficiency accelerates atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 32:1613–1623. http://dx.doi.org/10.1161/ATVBAHA.111.236539.
   PubMed Web of Science ®Google Scholar
• Pourcet B, Feig JE, Vengrenyuk Y, Hobbs AJ, Kepka-Lenhart D, Garabedian MJ, Morris SMJr, Fisher EA, Pineda-Torra I. 2011. LXRalpha regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8. Circ. Res. 109:492–501. http://dx.doi.org/10.1161/CIRCRESAHA.111.241810.
   PubMedGoogle Scholar
• Liu Y, Li S, Zhang H, Wan Z, Zhang X, Du R. 2012. A one-step cloning method for the construction of somatic cell gene targeting vectors: application to production of human knockout cell lines. BMC Biotechnol. 12:71. http://dx.doi.org/10.1186/1472-6750-12-71.
   PubMedGoogle Scholar
• Kuhel DG, Zhu B, Witte DP, Hui DY. 2002. Distinction in genetic determinants for injury-induced neointimal hyperplasia and diet-induced atherosclerosis in inbred mice. Arterioscler. Thromb. Vasc. Biol. 22:955–960. http://dx.doi.org/10.1161/01.ATV.0000017994.77066.75.
   PubMedGoogle Scholar
• Cho A, Reidy MA. 2002. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ. Res. 91:845–851. http://dx.doi.org/10.1161/01.RES.0000040420.17366.2E.
   PubMed Web of Science ®Google Scholar
• Li H, He C, Feng J, Zhang Y, Tang Q, Bian Z, Bai X, Zhou H, Jiang H, Heximer SP, Qin M, Huang H, Liu PP, Huang C. 2010. Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. Proc. Natl. Acad. Sci. U. S. A. 107:13818–13823. http://dx.doi.org/10.1073/pnas.1008397107.
   PubMed Web of Science ®Google Scholar
• Blank RS, Owens GK. 1990. Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. J. Cell. Physiol. 142:635–642. http://dx.doi.org/10.1002/jcp.1041420325.
   PubMed Web of Science ®Google Scholar
• Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. 1992. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89:507–511. http://dx.doi.org/10.1172/JCI115613.
   PubMed Web of Science ®Google Scholar
• Rensen SS, Doevendans PA, van Eys GJ. 2007. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Heart J. 15:100–108. http://dx.doi.org/10.1007/BF03085963.
   PubMed Web of Science ®Google Scholar
• Rzucidlo EM, Martin KA, Powell RJ. 2007. Regulation of vascular smooth muscle cell differentiation. J. Vasc. Surg. 45(Suppl A):A25–A32. http://dx.doi.org/10.1016/j.jvs.2007.03.001.
   PubMed Web of Science ®Google Scholar
• McDonald OG, Wamhoff BR, Hoofnagle MH, Owens GK. 2006. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J. Clin. Invest. 116:36–48. http://dx.doi.org/10.1172/JCI26505.
   PubMedGoogle Scholar
• Li S, Wang DZ, Wang Z, Richardson JA, Olson EN. 2003. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. U. S. A. 100:9366–9370. http://dx.doi.org/10.1073/pnas.1233635100.
   PubMed Web of Science ®Google Scholar
• Yoshida T. 2003. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ. Res. 92:856–864. http://dx.doi.org/10.1161/01.RES.0000068405.49081.09.
   PubMedGoogle Scholar
• Chen J, Kitchen CM, Streb JW, Miano JM. 2002. Myocardin: a component of a molecular switch for smooth muscle differentiation. J. Mol. Cell. Cardiol. 34:1345–1356. http://dx.doi.org/10.1006/jmcc.2002.2086.
   PubMedGoogle Scholar
• Cao D, Wang Z, Zhang CL, Oh J, Xing W, Li S, Richardson JA, Wang DZ, Olson EN. 2005. Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol. Cell. Biol. 25:364–376. http://dx.doi.org/10.1128/MCB.25.1.364-376.2005.
   PubMedGoogle Scholar
• Takaoka A, Tamura T, Taniguchi T. 2008. Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Sci. 99:467–478. http://dx.doi.org/10.1111/j.1349-7006.2007.00720.x.
   PubMedGoogle Scholar
• Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, Lou J, Knobeloch KP, Gabriele L, Waring JF, Bachmann MF, Zinkernagel RM, Morse HCIII, Ozato K, Horak I. 1996. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87:307–317. http://dx.doi.org/10.1016/S0092-8674(00)81348-3.
   PubMed Web of Science ®Google Scholar
• Scharton-Kersten T, Contursi C, Masumi A, Sher A, Ozato K. 1997. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J. Exp. Med. 186:1523–1534. http://dx.doi.org/10.1084/jem.186.9.1523.
   PubMedGoogle Scholar
• Giese NA, Gabriele L, Doherty TM, Klinman DM, Tadesse-Heath L, Contursi C, Epstein SL, Morse HCIII. 1997. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J. Exp. Med. 186:1535–1546. http://dx.doi.org/10.1084/jem.186.9.1535.
   PubMed Web of Science ®Google Scholar
• Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, Azevedo J, Fortin A, Haniffa M, Ceron-Gutierrez L, Bacon CM, Menon G, Trouillet C, McDonald D, Carey P, Ginhoux F, Alsina L, Zumwalt TJ, Kong XF, Kumararatne D, Butler K, Hubeau M, Feinberg J, Al-Muhsen S, Cant A, Abel L, Chaussabel D, Doffinger R, Talesnik E, Grumach A, Duarte A, Abarca K, Moraes-Vasconcelos D, Burk D, Berghuis A, Geissmann F, Collin M, Casanova JL, Gros P. 2011. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365:127–138. http://dx.doi.org/10.1056/NEJMoa1100066.
   PubMed Web of Science ®Google Scholar
• Leonard D, Svenungsson E, Sandling JK, Berggren O, Jonsen A, Bengtsson C, Wang C, Jensen-Urstad K, Granstam SO, Bengtsson AA, Gustafsson JT, Gunnarsson I, Rantapaa-Dahlqvist S, Nordmark G, Eloranta ML, Syvanen AC, Ronnblom L. 2013. Coronary heart disease in systemic lupus erythematosus is associated with interferon regulatory factor 8 gene variants. Circ. Cardiovasc. Genet. 6:255–263. http://dx.doi.org/10.1161/CIRCGENETICS.113.000044.
   PubMedGoogle Scholar
• Teupser D, Burkhardt R, Wilfert W, Haffner I, Nebendahl K, Thiery J. 2006. Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance. Arterioscler. Thromb. Vasc. Biol. 26:365–371. http://dx.doi.org/10.1161/01.ATV.0000195791.83380.4c.
   PubMedGoogle Scholar
• Nguyen AT, Gomez D, Bell RD, Campbell JH, Clowes AW, Gabbiani G, Giachelli CM, Parmacek MS, Raines EW, Rusch NJ, Speer MY, Sturek M, Thyberg J, Towler DA, Weiser-Evans MC, Yan C, Miano JM, Owens GK. 2013. Smooth muscle cell plasticity: fact or fiction? Circ. Res. 112:17–22. http://dx.doi.org/10.1161/CIRCRESAHA.112.281048.
   PubMed Web of Science ®Google Scholar
• Liu ZP, Wang Z, Yanagisawa H, Olson EN. 2005. Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev. Cell 9:261–270. http://dx.doi.org/10.1016/j.devcel.2005.05.017.
   PubMedGoogle Scholar